Ocular Therapeutix (NSDQ:OCUL) said yesterday that its chief financial officer, Bradford Smith, will resign from the company at the end of this month. James Fortune, Ocular’s chief operating officer, will assume the roles of principal financial officer and principal accounting officer, according to a regulatory filing. Get the full story at our sister site, Drug Delivery […]
Abbott
ACC 2017 Roundup: Abbott touts reduced HF rehospitalizations in MitraClip study
The team at MassDevice.com and Drug Delivery Business News will be updating this post periodically as news comes out of ACC 2017, the annual American College of Cardiology meeting in Washington March 17-19. Abbott touts reduced HF rehospitalizations in MitraClip study Abbott (NYSE:ABT) released 1-year outcomes from the largest study to-date of real-world experiences […]
ACC 2017: FDA warns on Abbott’s Absorb
The Absorb bioresorbable stent made by Abbott (NYSE:ABT) confers a higher risk of serious adverse events at 2 years compared with the company’s Xience drug-eluting stent, according to new data from a study that prompted the FDA to warn physicians on the risk. But the picture is clouded by new guidelines indicating the proper blood vessel […]
Pharma stocks fall on Trump’s proposal to cut NIH budget
The Trump budget plan to slash more than 18% from the budget for the National Institutes of Health sent pharmaceutical stocks down today on Wall Street as investors reacted to the proposal. The budget proposal, released today, would cut the NIH budget by $5.8 billion, to $25.9 billion – an 18.3% cut. The proposal would also introduce […]
Alere misses extended 10-K filing date
UPDATE: Updated to include new information on Alere’s suit against CMS Alere (NYSE:ALR) said today it will be unable to file its annual 10-K report by its extended March 16 deadline due to an investigation of inappropriate conduct at its South Korean Standard Diagnostics subsidiary. The Waltham, Mass.-based company filed for the extension on March 1 […]
Abbott wins FDA nod for FlexAbility sensor-enabled ablation cath
Abbott (NYSE:ABT) said today it won FDA approval for its sensor-enabled FlexAbility ablation catheter designed for cardiac ablation procedures to treat atrial flutter. The sensor-enabled FlexAbility ablation catheter is the Abbott Park, Ill.-based company’s 1st designed to collect electrical current resistance and magnetic data to produce accurate mapping and assist in treating sites that trigger […]
Alere slides after revealing new Asia accounting snafu
UPDATED March 1, 2017, with analyst comment, share price. Alere (NYSE:ALR) said today that it’s once again unable to file its annual report by the deadline, after an ongoing probe into its accounting practices turned up yet another irregularity, this time with how it recognized revenues in Asia. The news adds fuel to the fire over the […]
Johnson & Johnson closes $4.3B Abbott Medical Optics buy
Johnson & Johnson (NYSE:JNJ) said today that it closed the $4.33 billion buyout of Abbott Medical Optics from Abbott (NYSE:ABT). The deal for AMO, announced in September 2016, includes its portfolio of ophthalmic products covering cataract surgery, laser refractive surgery and consumer eye health. The business posts annual sales of $1.1 billion and is slated to be folded into the medical […]
Study: Abbott’s CardioMEMS monitor performs better in real world than pivotal trial
Real-world results from patients with Abbott‘s (NYSE:ABT) CardioMEMS implantable heart monitor, which it acquired along with St Jude Medical in Jan., show greater reduction in pulmonary artery pressure than seen in the pivotal Champion clinical trial of the device, according to a new study. The study examined the 1st 2,000 patients implanted with the CardioMEMS device […]
Abbott denies reports it will bail on India’s high-end stent market
Abbott (NYSE:ABT) yesterday denied reports that it’s pulling its high-end coronary stents from India’s market, after the government there put price caps in place for a variety of medical devices and drugs, including stents. India’s National Pharmaceutical Pricing Authority last week issued an order capping the price of stents at about $108 (Rs 7,260) for bare-metal devices […]
Abbott floats bid to exchange St. Jude senior notes
Abbott (NYSE:ABT) said today it opened offers looking to exchange notes offered by St. Jude Medical, which it acquired for $25 billion last month, for notes issued by Abbott. Included are St Jude’s 2% senior notes due 2018, 2.8% senior notes due 2020, 3.25% senior notes due 2023, 3.875% senior notes due 2025 and 4.75% senior notes due 2043, […]